Sulfur-containing ligands improve the inhibitor activity for thrombosis Factor Xa (FXa) and selectivity as for MMP-13 inhibitors (Metalloproteinase) therapeutically useful for curing osteoarthritis (Zhang et al. 2015). The gene discussed is F10; the disease is osteoarthritis.